Table of Contents

Spiriva Respimat is a type of inhaler that delivers tiotropium bromide in a soft mist. It belongs to a group of medicines called long-acting muscarinic antagonists (LAMA). These help make breathing easier by relaxing the muscles around your airways, keeping them open. This inhaler is used every day to help manage long-term breathing conditions like COPD and asthma. It’s not meant to treat sudden breathing problems.

Knowing the right dose and how to use it correctly can help you manage symptoms better and avoid unwanted effects. This comprehensive guide breaks down the correct Spiriva Respimat dosage regimens, administration tips, age-related recommendations, and other clinical considerations for Spiriva Respimat.

Key Takeaways

  • Spiriva Respimat is a long-term maintenance inhaler, not a rescue medication, used to improve breathing and prevent flare-ups in both COPD and asthma.
  • The device delivers different doses depending on whether it’s used for COPD or asthma, and comes in two distinct color-coded versions to help avoid mix-ups. Teal/aqua is used for COPD (5 mcg daily), and blue is for asthma (2.5 mcg daily), making it easier for patients and caregivers to differentiate.
  • Its once-daily dosing, two puffs at the same time every day, supports adherence while delivering consistent medication levels. This simple routine helps patients stay on track and maintain symptom control over time.
  • Despite changes in kidney function, no formal dose adjustment is required, though patients with moderate to severe renal impairment should be monitored closely. Drug exposure increases with reduced kidney function, which may raise the chance of anticholinergic side effects like dry mouth or a fast heart rate.
  • Age-related declines in kidney clearance do not seem to affect the drug’s safety in older adults, and no dose change is recommended in this group.
  • The inhaler requires proper priming before first use and careful handling with weekly cleaning to ensure it functions correctly and delivers accurate doses.
  • Built-in dose tracking and an automatic lock feature help users avoid overdosing or unknowingly using an empty inhaler.
  • Missed doses should not be doubled as they may cause noticeable anticholinergic symptoms and require prompt medical attention.

What Is Spiriva Respimat Used For?

Spiriva Respimat Inhaler

Spiriva Respimat is approved for the following uses:

    • Chronic Obstructive Pulmonary Disease (COPD): Long-term, once-daily maintenance treatment of airflow obstruction and to reduce exacerbations in individuals with COPD, including chronic bronchitis and emphysema.
    • Asthma: Maintenance treatment of asthma in patients aged 6 years and older when symptoms are not well controlled with inhaled corticosteroids (ICS) and long-acting beta agonists (LABA).

Spiriva Respimat Dosage

Your dosage of Spiriva Respimat depends on the condition you’re treating and your age.

Spiriva Dosing for COPD

For adults with COPD, use the Spiriva Respimat with the teal/green cap or label, also referred to as the one with the aqua cap.

The recommended dose is 2 inhalations of 2.5 mcg once a day, giving a total of 5 mcg of tiotropium daily. It’s best to take the inhalations at the same time each day.

This dosing is approved for adults with COPD, including those with chronic bronchitis or emphysema. Spiriva hasn’t been well studied in children with COPD and isn’t approved for use in pediatric patients.

Researchers conducted a 3-week trial in 202 adults with COPD to determine the best dose. Participants received a placebo or Spiriva Respimat at doses from 1.25 to 20 mcg once daily. All doses improved lung function (trough FEV1), but 5 mcg and 10 mcg showed the most consistent results and were chosen for Phase III trials.

In five major COPD trials, Spiriva Respimat 5 mcg improved lung function and reduced the need for rescue inhalers. In Trials 3 and 4, it cut flare-ups by about 22%. Trial 5 showed it delayed the first flare-up, reduced yearly exacerbation rates, and lowered hospitalization risk by about 27% compared to placebo.

Spiriva Respimat Dose for Asthma

For asthma management, use the Spiriva Respimat with the blue label or cap. The recommended dosage is 2 inhalations of 1.25 mcg once daily, for a total daily dose of 2.5 mcg of tiotropium bromide.

Dosage remains the same across the approved pediatric age range. Researchers tested different doses of Spiriva Respimat in adults, teens (ages 12-17), and children (ages 6-11) with asthma.

They tried doses between 1.25 mcg and 10 mcg once a day. All doses improved breathing compared to a placebo, but the improvements didn’t always increase with higher doses.

In adults, the 5 mcg dose improved lung function the most, but even the lower doses showed benefits. In teens and kids, improvements were also seen at all dose levels, with 2.5 mcg and 5 mcg performing better than 1.25 mcg in most cases.

Missed Dose and Overdose

If you miss a dose, take it as soon as you remember, unless it’s almost time for your next scheduled dose. In that case, skip the missed dose and just take the next one as planned. Do not take extra puffs to make up for the missed dose.

On the other hand, taking too much Spiriva may cause anticholinergic side effects. These can include dry mouth, blurred vision, and a fast heart rate. If you think you’ve taken too much, seek medical help right away.

Dose Adjustments in Special Populations

Elderly woman using Spiriva Respimat Inhaler

As the kidneys are primarily responsible for clearing Spiriva Respimat, keep in mind possible dosage concerns in the following populations:

1. Older adults aged 65 and older

As people age, kidney function tends to decline. However, according to the manufacturer, no dosage adjustment is advised for older adults.

In COPD patients, kidney clearance of the drug dropped from 347 mL/min in those under 65 to 275 mL/min in those 65 and older. However, this didn’t lead to higher drug levels in the blood after inhalation. In asthma patients, age did not affect how much of the drug the body absorbed.

2. Kidney issues

If your kidney function is reduced (creatinine clearance less than 60 mL/min), you may be more at risk for side effects like dry mouth or constipation and need close monitoring.

Clinical trials showed that in people with COPD:

    • Mild kidney issues led to a 23% increase in total drug exposure and a 17% increase in peak levels.
    • Moderate kidney issues led to a 57% increase in total exposure and a 31% increase in peak levels compared to people with normal kidney function.

This means more of the drug stays in your body and reaches higher levels, which could increase the risk of side effects.

These effects were similar in asthma patients.

There isn’t enough data on how the drug behaves in people with very poor kidney function (creatinine clearance under 30 mL/min) after inhalation. But from IV studies, exposure levels were nearly double in this group.

Despite these increases, no dose adjustment is officially required, but close monitoring is recommended.

3. Liver problems

The effect of liver problems on how the drug is processed hasn’t been studied.

Spiriva Respimat’s Instructions for Use

Spiriva Respimat is a soft mist inhaler used once daily to manage COPD or asthma. It delivers medication into your lungs to help open your airways. Each inhaler contains 60 puffs, enough for 30 days at 2 puffs once a day.

Preparing Spiriva Respimat for First Use

This step only needs to be done once, when using a new inhaler:

  • 1. Assemble the Inhaler

      • Press the safety catch on the side of the inhaler.
      • Pull off the clear base with your other hand.
      • Insert the cartridge (narrow end first) into the inhaler body.
      • Push the cartridge down firmly until it clicks into place.
      • Reattach the clear base until it clicks.
    Tip: Placing the inhaler on a hard surface and pressing the cartridge down can help insert it more securely.

  • 2. Prime the Inhaler (Release Test Sprays)

      • This ensures the device is ready to deliver full doses.
      • Hold the inhaler upright with the cap closed.
      • Turn the clear base half a turn in the direction of the arrows until it clicks.
      • Flip open the cap.
      • Point the inhaler toward the ground (away from face).
      • Press the dose-release button.
      • Repeat this turn-open-press cycle until you see a mist.
      • Continue priming until you see a mist 3 times.
    Tip: It usually takes 4-5 priming sprays before you get a visible mist. Now it’s ready to use.

How to Take Your Daily Spiriva Respimat Dose

You only need to do this once daily, taking 2 puffs at the same time each day.

1. Hold the Inhaler Upright and Load the Dose

    • Keep the cap closed.
    • Hold the device upright.
    • Turn the clear base in the direction of the arrows until it clicks (half a turn).

2. Open the Cap

    • Flip open the cap until it clicks open fully.

3. Exhale (Away from the Inhaler)

    • Breathe out fully and slowly, not into the inhaler.

4. Inhale the Medication

    • Place the mouthpiece between your lips, forming a tight seal.
    • Start breathing in slowly and deeply through your mouth.
    • While breathing in, press the dose-release button and continue inhaling.
    • Hold your breath for about 10 seconds (or as long as comfortable).

5. Repeat for the Second Puff

    • Close the cap.
    • Repeat steps 1-4 for the second puff.

Cleaning the Inhaler (Weekly)

Wipe the mouthpiece (inside and outside) with a damp cloth or tissue. Do not use water directly or take the device apart. If the mouthpiece becomes slightly discolored, it does not impact the medicine or delivery.

Tracking Doses

Your Spiriva Respimat inhaler has a built-in scale that shows how many puffs are left. As you continue using the inhaler, the dose indicator will gradually move. It shows approximately how many puffs remain. When the indicator starts to move into the red zone, that means the inhaler is running low, and it’s time to get a refill.

Once the indicator reaches the end of the red zone, the inhaler is empty. At this point, the device will lock automatically, and you won’t be able to turn the clear base anymore to prepare another dose.

Throw away the Spiriva Respimat inhaler three months after inserting the cartridge, even if you haven’t used all the medication. Also discard it if the inhaler becomes locked or if it reaches its expiration date, whichever comes first.

Final Takeaway

Spiriva Respimat comes in different doses depending on whether you have COPD or asthma. Adults with COPD usually take 5 mcg once a day. For asthma, the daily dose is 2.5 mcg. This inhaler is meant to be used every day, not just when symptoms appear. It helps keep your airways open over time and should only be used as directed by your doctor.

Using the right dose each day can help you breathe easier and manage your symptoms more effectively. It also supports long-term lung health when used consistently.

Frequently Asked Questions

Yes, Spiriva Respimat is often used in combination with other inhalers. It’s a maintenance bronchodilator and works well with short-acting bronchodilators like albuterol for quick relief, or with inhaled corticosteroids for better asthma or COPD control. Always follow your healthcare provider’s guidance when combining inhalers.

Although Spiriva Respimat isn’t meant for quick relief, some users may notice easier breathing within the first few hours. However, the full benefit usually builds over time with consistent use. For asthma patients in particular, it may take 4 to 8 weeks of regular use before the maximum improvement in symptoms becomes noticeable.

There is limited data on the safety of Spiriva during pregnancy or while nursing. Your healthcare provider will weigh the benefits against potential risks and may recommend an alternative if safety concerns arise.

If the mist isn’t coming out despite the dose indicator showing remaining puffs, try cleaning the mouthpiece and priming the inhaler again. If it still doesn’t work, the device may be faulty and should be replaced.

No. Spiriva Respimat is only approved for children (aged 6 and up) with asthma that’s not well-controlled by standard therapy. It has not been studied or approved for pediatric use in COPD or other respiratory conditions.

There are no specific food or drink restrictions. However, you should avoid smoking, exposure to allergens, or activities that worsen your breathing. Also, be cautious if you’re doing anything requiring sharp vision, as rare side effects like blurred vision can occur.

Related Articles

Sources

Us, B. I. (2025, May 26). Treatment Options | Spiriva® Respimat® (tiotropium bromide) Inhalation Spray. Spiriva® Respimat® Inhalation Spray. https://patient.boehringer-ingelheim.com/us/products/spiriva/